Glyxambi
Active Ingredient(s): Empagliflozin + LinagliptinFDA Approved: * January 30, 2015
Pharm Company: * BOEHRINGER INGELHEIM
Category: Diabetes
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Glyxambi Overview
Empagliflozin/linagliptin, sold under the brand name Glyxambi, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[5][6] It is a combination of empagliflozin and linagliptin.[5][6] It is taken by mouth.[5][6] The most common side effects include urinary infections, nasopharyngitis, and upper respiratory tract infections .[5][6] It was ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Empagliflozin/linagliptin
Recent Glyxambi Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Empagliflozin + Linagliptin
- Tablet: 10mg + 5mg, 25mg + 5mg
NDC Database Records for Glyxambi: (3 results)
Sorted by National Drug Code- 0597-0164 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0182 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.
- 70518-2046 Glyxambi Oral Tablet, Film Coated by Remedyrepack Inc.
Drugs with one or more similar ingredients: (12 results)
- EMPAGLIFLOZIN + LINAGLIPTIN
- EMPAGLIFLOZIN
- EMPAGLIFLOZIN + LINAGLIPTIN + METFORMIN HYDROCHLORIDE
- EMPAGLIFLOZIN + METFORMIN
- JARDIANCE Empagliflozin21 discussions
- JENTADUETO XR Linagliptin + Metformin Hydrochloride
- LINAGLIPTIN
- LINAGLIPTIN + METFORMIN HYDROCHLORIDE
- SYNJARDY Empagliflozin + Metformin Hydrochloride
- SYNJARDY XR Empagliflozin + Metformin Hydrochloride
- TRADJENTA Linagliptin4 discussions
- TRIJARDY XR Empagliflozin + Linagliptin + Metformin Hydrochloride